BIO-Europe Spring 2019: Modra Pharmaceuticals CEO On Enhancing Taxanes
Executive Summary
Modra Pharmaceuticals’ three goals are to improve the toxicity, the efficacy and the formulation of taxane chemotherapies used to treat cancer. CEO Colin Freund spoke to Mike Ward.